PYXS Pyxis Oncology, Inc.: institutional ownership and insider trading
89 funds reported holding $106M of Pyxis Oncology, Inc. in their latest 13F filings; in Q2 2026 funds net bought $21.0M, with 11 new positions and 9 funds selling out; over the last 12 months insiders bought $0 and sold $107K on the open market.
Famous investors holding PYXS
- Renaissance Technologies (Renaissance Technologies): $2.32M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $701K, 0.0% of the portfolio
- Two Sigma (Two Sigma Investments): $253K, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $187K, 0.0% of the portfolio
Largest institutional holders of PYXS
- GordonMD Global Investments LP — $30.2M
- PFIZER INC (PFE) — $19.5M
- Laurion Capital Management LP — $14.8M
- VANGUARD CAPITAL MANAGEMENT LLC — $6.25M
- Atle Fund Management AB — $2.91M
- VANGUARD GROUP INC — $2.69M
- BlackRock, Inc. (BLK) — $2.61M
- Palo Alto Investors LP — $2.60M
- MARSHALL WACE, LLP — $2.50M
- RENAISSANCE TECHNOLOGIES LLC — $2.32M
Recent PYXS insider trades
- Jun 30, 2026: Dupont Jakob sold 35,000 shares ($107K)
- Apr 21, 2025: Humphrey Rachel sold 15,496 shares ($15.9K)
- Nov 26, 2024: Connealy Pamela Ann bought 88,850 shares ($174K)
5%+ owners
- GordonMD Global Investments LP: 16.4% (Schedule 13G/A, filed Oct 9, 2026)
- BVF PARTNERS L P/IL: 10.0% (Schedule 13G, filed Jul 10, 2026)
- Coastlands Capital LP: 5.4% (Schedule 13G, filed Oct 5, 2026)